TrialBritish journal of clinical pharmacology2019

Pharmacokinetics and safety of tobramycin nebulization with the I-neb and PARI-LC Plus in children with cystic fibrosis: A randomized, crossover study.

Annelies J van Velzen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.